Cyclerion Therapeutics (CYCN) Total Non-Current Liabilities (2019)

Cyclerion Therapeutics (CYCN) recorded quarterly Total Non-Current Liabilities of $17.5 million in Q1 2019.

Cyclerion Therapeutics (CYCN) Total Non-Current Liabilities (2019) Analysis & Trends

Cyclerion Therapeutics' Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $17.5 million for Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 42,980.09
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 11.03 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 644,700.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 5.87 Bn
9 Abivax 94.37 Bn 94.37 Bn - 64.76 Mn
10 Cyclerion Therapeutics 11.50 Mn 8.26 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2019 17.47 Mn